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ORIGINAL RESEARCH ARTICLE Open Access
The Impact of Gastrointestinal Symptoms
and Dermatological Injuries on Nutritional
Intake and Hydration Status During
Ultramarathon Events
Ricardo J. S. Costa1*, Rhiannon Snipe1, Vera Camões-Costa1, Volker Scheer2 and Andrew Murray3
Abstract
Background: Debilitating gastrointestinal symptoms (GIS) and dermatological injuries (DI) are common during and
after endurance events and have been linked to performance decrements, event withdrawal, and issues requiring
medical attention. The study aimed to determine whether GIS and DI affect food and fluid intake, and nutritional
and hydration status, of ultramarathon runners during multi-stage (MSUM) and 24-h continuous (24 h)
ultramarathons.
Methods: Ad libitum food and fluid intakes of ultramarathon runners (MSUM n = 54; 24 h n = 22) were recorded
throughout both events and analysed by dietary analysis software. Body mass and urinary ketones were
determined, and blood samples were taken, before and immediately after running. A medical log was used to
monitor symptoms and injuries throughout both events.
Results: GIS were reported by 85 and 73 % of ultramarathon runners throughout MSUM and 24 h, respectively. GIS
during MSUM were associated with reduced total daily, during, and post-stage energy and macronutrient intakes
(p < 0.05), whereas GIS during 24 h did not alter nutritional variables. Throughout the MSUM 89 % of ultramarathon
runners reported DI. DI during MSUM were associated with reduced carbohydrate (p < 0.05) intake during running
and protein intake post-stage (p < 0.05). DI during 24 h were low; thus, comparative analyses were not possible.
Daily, during running, and post-stage energy, macronutrient and water intake variables were observed to be lower
with severity of GIS and DI (p < 0.05) throughout the MSUM only.
Conclusions: GIS during the MSUM, but not the 24 h, compromised nutritional intake. DI presence and severity
also compromised nutrient intake during running and recovery in the MSUM.
Key Points
– Gastrointestinal symptoms (GIS) were a common
feature in both the MSUM and 24 h; however,
dermatological injuries (DI) were high during the
MSUM, but relatively low during the 24 h.
– Incidence and severity of GIS appeared to be
associated with greater disturbances to daily energy
balance, reduced daily macronutrient intake, and
reduced nutritional intake during running and
recovery throughout the MSUM, but not the 24 h.
– Incidence and severity of DI appeared to be
associated with reduced nutritional intake during
running and recovery throughout the MSUM.
Background
Ultramarathon running events (>42.195 km) have in-
creased in popularity over the past decade [1] and are
predicted for future growth within recreational endur-
ance sports participation. Despite popularity, research
into the demands of such an extreme sport is scarce in
comparison to shorter endurance running events (e.g.
marathon and sub-marathon) [2]. Participation in ultra-
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endurance events often requires competitors to perform
loaded prolonged physical exertion, sleep rough on con-
secutive days, and manage food and fluid provisions
throughout competition to maintain performance and
avoid adverse health outcomes [3, 4]. Such diverse
challenges demonstrates the uniqueness of extreme en-
durance sports and highlights areas for potential per-
formance decrements and health issues to exacerbate.
Extreme energy deficits are a common feature of con-
tinuous and multi-stage ultramarathon running events
and have been associated with poor recovery quality and
sustained fatigue [5, 6]. Development of unintentional
symptoms (e.g. gastrointestinal) and injury (e.g. derma-
tological) may limit total food and fluid intake during
consecutive days of exertional stress with and without
the additional impact of environmental extremes [3, 7].
Moreover, sub-optimal nutrition and hydration during
periods of extreme exertion is clinically relevant, having
been implicated in exacerbating exercise-induced immu-
nodepression, impaired repair and healing, cytokine dys-
function associated with chronic fatigue, rapid onset
microcytic anaemia, exercise-induced rhabdomyolysis,
and exertional heat illnesses [3, 8–13].
Gastrointestinal symptoms (GIS) are a common fea-
ture of endurance sports and appear to be more pro-
nounced in running compared to other exercise modes
[14] and greater in a dehydrated state compared with a
euhydrated state [15]. Indeed, 93 % of a participant co-
hort reported GIS during a long distance triathlon event,
with upper-GIS (e.g. belching, bloating, and vomiting)
and nausea reported to predominate [16]; whereas 60 %
of ultramarathon runners during a continuous 161-km
ultramarathon reported upper- (e.g. vomiting) and lower
(e.g. abdominal cramps and diarrhoea)-GIS, with 89 % of
participants with symptoms also reporting nausea [17].
Gastrointestinal symptoms (e.g. nausea and vomiting)
have also been reported to be a key contributing factor
in performance decrements and event withdrawal during
ultramarathon running competition [18, 19].
The causes of GIS during prolonged exertion are
multi-factorial in origin. Splanchnic hypoperfusion, is-
chaemia, alterations to intestinal motility, and mechan-
ical trauma appear to play a key role [15, 20, 21]. When
exertion is performed in hot environmental conditions
(>30 °C), enhanced thermoregulatory strain, increased
body water losses, and accompanying hypovolaemia pro-
mote further splanchnic hypoperfusion, ischaemia, and
disruption of intestinal epithelial integrity [22–24]. Such
perturbations have been linked to increased epithelial
permeability of bacterial endotoxins, originating from
the intestinal microbiota, leading to endotoxaemia and
subsequent responsive cytokinaemia [25, 26], in which
nausea is a common feature. Moreover, nausea and
(or) vomiting has also been reported during episodes
of heat illness [27], asymptomatic and symptomatic
exercise-associated hyponatremia (with or without en-
cephalopathy) [28, 29], and may occur if ultramara-
thon runners attempt to meet high energy and water
demands through constant forced feeding and stimu-
lation of the ileal brake [30].
Dermatological injuries (DI) (e.g. blisters, subungual
haematoma, chafing, abrasions, and sunburn) are also a
common feature of endurance sports [4, 31–33]. Derma-
tological injuries account for the greatest number of
medical interventions and event withdrawals during
multi-stage ultramarathon events [7, 33, 34] and the
prime factor to adversely affect performance in continu-
ous ultramarathon competition [18, 35]. The main
causes of such injuries are excessive frictional forces and
surface exposure, which are exacerbated by heat, poorly-
fitted clothing and equipment, carrying load, and
individual characteristics (i.e. skin surface roughness)
[33, 36]. An anecdotal observational case scenario from
the seven-stages 245 km 2008 Marathon des Sables indi-
cated that all members (n = 6) of tent 96 developed foot
injuries by stage 2, with injury numbers and severity in-
creasing thereafter. All members reported investing a
substantial amount of time with injury care and pain
management (i.e. 2–3 h during recovery; including self-
management, awaiting and receiving medical attention),
deterring focus and priority away from scheduled feed-
ing regimes, and potentially creating a barrier towards
meeting high nutritional and hydration requirement,
which can substantially effect running performance.
To date, the impact of GIS and DI on nutritional in-
take and hydration status during continuous ultramara-
thon events longer than 161 km, and multi-stage
ultramarathon events, has not been thoroughly investi-
gated. The purpose of this study was to determine
whether GIS or DI affects food and fluid intake, and nu-
trition and hydration status, of ultramarathon runners
during a multi-stage ultramarathon and a 24-h continu-
ous ultramarathon.
Methods
Ultramarathon Events and Participants
The multi-stage ultramarathon (MSUM) component of the
study was conducted during the 2010 and 2011 Al Andalus
Ultimate Trail (www.alandalus-ut.com), held during the
second week of July, in the region of Loja, Spain (Table 1).
The 24-h continuous ultramarathon (24 h) component of
the study was conducted during the 2011 and 2012 Glen-
more24 Trail Race (http://runyabam.com/glenmore-24/),
held during the first week of September, in the Cairn-
gorms National Park, Scottish Highlands, UK.
After ethical approval from the University Ethics
Committee that conforms with the Helsinki declaration
for human research ethics, 74 out of 134 ultramarathon
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runners entered in the MSUM event, and 25 out of 48
ultramarathon runners entered in the 24 h event pro-
vided informed consent to participate in the study. How-
ever, complete gastrointestinal and dermatological
profiles and nutritional and hydration variables were ob-
tained in n = 54 and n = 22 for the MSUM and 24 h
events, respectively (Table 1). Only participants who pre-
sented complete gastrointestinal and dermatological pro-
files and nutritional and hydration variables were used in
comparative data analysis.
Study Design and Data Collection
Both ultramarathons were self-sufficient, whereby partic-
ipants planned and provided their own ad libitum foods
and fluids along the duration of the events. Only plain
water was provided by the race organisers. Aid stations
along the running course were situated approximately
10 and 3 km apart for the MSUM and 24 h, respectively.
For the MSUM, estimated total daily energy expenditure
was calculated through predictive equations [37] and
verified through SenseWear (7.0, BodyMedia Inc.,
Pittsburgh, PA, USA) in a sub-sample of ultramarathon
runners using convenience sampling (22 verifications,
coefficient of variation 5.6 %), as previously used to
guide sports dietetic support during MSUM competition
[38]. For the 24 h, estimated total energy expenditure
was determined by SenseWear in all participants. The
triaxial accelerometry, which also included measure-
ments of heat flux, skin temperature, and galvanic skin
responses, was attached firmly to the upper arm of the
participants, over the mid-point of the triceps muscle,
during the measurement period. Data were processed
using proprietary algorithms available in the software
(version 7.0, algorithm version 2.2.4).
Before the start of each event (and each stage of the
MSUM), participants were asked to provide a mid-flow
urine sample into 30 ml universal tubes, followed by
body mass and height measurements. Participants were
then required to sit for 10 min before blood sampling.
Whole blood samples were collected by venepuncture
without venostasis from an antecubital vein using a 21G
butterfly syringe into one lithium heparin (6 ml, 1.5 IU/
ml heparin; Becton Dickinson, Oxford, UK) and one
K3EDTA (6 ml, 1.6 mg/ml of K3EDTA; Becton Dickin-
son, Oxford, UK) vacutainer tube. Blood samples were
immediately centrifuged and plasma aliquoted into
eppendorfs and stored frozen initially at −20 °C during
the ultramarathon events in a sterile field laboratory
setup, prior to transferring to −80 °C storage after com-
pletion of the experimental procedure. Immediately after
event completion (and each stage of the MSUM), blood
samples were collected, followed by a mid-flow urine
sample at the earliest convenience.
At the end of each competition day on stages 1 to 4 in
the MSUM, and within the hour after event completion
in the 24 h, trained researchers conducted a standar-
dised interview on participants and support crews to as-
certain all foods and fluids ingested, symptoms, and
injuries. To improve dietary recording accuracy, before
competition, participants and their support crews were
educated and instructed to record in detail all foods and
fluids ingested during the competition period (i.e. pre,
during, immediately post (within 1 h of cessation), and
rest periods, as per MSUM and 24 h relevance) in real
time. Additionally, participants and support crews were
instructed to keep food and beverage packaging of all
foods and fluids consumed, which were collected by
researchers.
Gastrointestinal symptoms and DI were explored
through a symptomology tool and a medical log with
physician verification. A Likert-type rating scale was
used to quantify GIS, whereby symptoms were classified
as indicated by ≥50 mm on a standard 100 mm visual
analogue scale, with 0 mm indicative of no symptoms to
100 mm indicative of extreme symptoms resulting in
event withdrawal. Severity of GIS was classified as low,
moderate, and high based on the incidence of GIS re-
ported (1 GIS, 2–3 GIS, and ≥4 GIS; respectively).
Table 1 Participant and event characteristics of the multi-stage
(MSUM) and 24-h continuous (24 h) ultramarathons
MSUM 24 h
Participant
characteristics
Total (n) 54 22
Male 33 16
Female 21 6
Age (year) 40 ± 8 40 ± 7
Height (m) 171 ± 15 177 ± 8
Body mass (kg) 70 ± 11 78 ± 11
Number of
previous
ultramarathon
events
5 ± 7 16 ± 13
Ultramarathon
characteristics
Distance (km) total 225 range 122 to 208
Ambient
temperature (°C)
range 32 to 40 range 0 to 20
Relative humidity
(% range)
range 32 to 40 range 54 to 82
Altitude (m) range 473 to 1443 range 39 to 645
Course
description
Off-road trails and paths,
steep and narrow
mountain passes,
and occasional
road
Off-road terrains, including
trails, paths, and grasslands
Mean ± SD (otherwise specified)
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Dermatological injuries were classified through visual
identification. Severity of DI was also classified as low,
moderate, and high based on the reported incidence of
DI, the level of self-management and (or) medical inter-
vention by the medical crew the injury received, associ-
ated pain severity (0 = no pain, 1 = minimal pain, 2 =
mild pain, 3 = moderate pain, 4 = severe pain, and 5 =
elimination from event), and evidence of established and
progressive infection and inflammation through phys-
ician verification. Additionally, to determine carbohy-
drate adequacy, urine reagent strips (10SG urinalysis
strips, Siemans Healthcare Diagnostic, NY, USA) were
used to identify urinary ketones (i.e. acetoacetic acid) in
pre- and post-running urine samples [12].
Dietary Analysis
Food and fluid ingestion records from both ultramara-
thon events were used to calculate energy, nutrient, and
water intake variables through Dietplan6 dietary analysis
software (v.6.60, Forestfield Software, Horsham, West
Sussex, UK). To improve the validity of the dietary ana-
lysis, all the nutritional information gathered from food
and beverage packages were entered into the dietary
analysis software program. In addition, to improve the
reliability of the dietary analysis, all the completed diet-
ary interview logs were blindly analysed by a second-
trained researcher.
Assessment of Hydration Status
Pre- and post-running plasma osmolality (POsmol) was
determined from 50 μl lithium heparin plasma sam-
ples in duplicate by freezepoint osmometry (Osmomat
030, Gonotec, Germany), as recommended previously
[39]. Whole blood K3EDTA samples were used to de-
termine haemoglobin concentration and haematocrit
through a cell counter (Coulter ACT Diff, Beckham
Coulter, USA), which were subsequently used to esti-
mate changes in plasma volume (PV) relative to pre-
competition values [40].
Data Analysis
Data in the text, tables, and figures are presented as
mean value ± standard deviation (SD), unless otherwise
specified. Considering the potential influence of individ-
ual body mass differences on dietary intake variables,
data analysis was performed on total values and adjusted
for body mass [5, 6, 41]. Diagnostic checks (Shapiro–
Wilks test of normality and Levene’s homogeneity of
variance test) were performed before applying paramet-
ric statistics (SPSS v.22, IL, US). One-way ANOVA (or
Kruskal–Wallis one-way) was applied to determine stage
differences in GIS and DI incidence and impact of sever-
ity of symptoms and injuries on dependant variables.
Significant main effects were analysed using post hoc
Tukey’s HSD test. Independent-sample t test (or Mann–
Whitney U test) was applied to determine dependant
variable differences between groups (GIS and DI), in-
cluding sub-group comparisons (running speed (slow ul-
tramarathon runners: average speed <8 km/h and fast
ultramarathon runners: average speed ≥8 km/h) and
sexes). Significance was accepted at p < 0.05.
Results
Gastrointestinal Symptoms
Gastrointestinal symptoms were a common feature dur-
ing the MSUM, with 85 % of the study cohort presenting
at least one GIS along the event (Fig. 1a). No statistically
significant differences in GIS incidence or severity were
observed between stages. No significant difference in
GIS were observed between sexes. However, male ultra-
marathon runners reported greater occurrence (p = 0.04)
of diarrhoea along the MSUM. Despite the presence of
GIS being associated with a slower time to completion
(28 h 43 min ± 4 h 32 min; 7.9 ± 1.3 km/h) compare with
no-GIS (25 h 52 min ± 4 h 12 min; 8.9 ± 1.3 km/h), no
significant difference in GIS was observed for running
speed.
Gastrointestinal symptoms were a common feature
during the 24 h, with 73 % of the study cohort present-
ing at least one GIS during the event (Fig. 1b). No sig-
nificant differences in GIS were observed between sexes.
Gastrointestinal symptoms were greater in fast (2.5-fold)
compared with slow ultramarathon runners (p < 0.01).
Fast ultramarathon runners reported greater occurrence
of urge to vomit (p = 0.04), vomiting (p = 0.04), belching
(p = 0.04), and diarrhoea (p = 0.04) compared with slow
ultramarathon runners. On the contrary to the MSUM,
the presence of GIS was not associated with a lower dis-
tance covered over the 24 h (166 ± 28 km; 6.9 ± 1.2 km/
h) compare with no-GIS (139 ± 15 km; 5.8 ± 0.6 km/h).
Dermatological Injuries
Throughout the MSUM, 89 % of participants presented
at least one DI, irrespective of severity. However, 76 % of
participants required self-management and (or) sought
(and received) medical intervention for DI. The inci-
dence (p < 0.01) and severity (p < 0.01) of DI significantly
increased as the MSUM progressed. No significant dif-
ference in DI incidence was observed between sexes and
running speed. However, the presence of DI were associ-
ated within a slower time to completion (29 h 03 min ±
4 h 39 min; 7.8 ± 1.3 km/h) compare with no-DI (26 h
38 min ± 4h39min; 8.7 ± 1.3 km/h). Dermatological in-
juries that required self-management and (or) medical
attention during the 24 h was low (14 %); thus, com-
parative analyses on intake and status variables were not
possible (Fig. 2).
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Hydration Status
No statistically significant difference in pre- and post-
stage POsmol (coefficient of variation: 3.5 %) was
observed between participants presenting GIS and no-
GIS in the MSUM (overall mean 286 ± 8 mOsmol/kg)
and the 24 h (overall mean 286 ± 11 mOsmol/kg) and
Fig. 1 Gastrointestinal symptoms of ultramarathon runners during a multi-stage ultramarathon (a) and a 24-h continuous ultramarathon (b)
(MSUM n = 54 and 24 h n = 22)
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Fig. 2 Dermatological injuries (a) and pain severity of dermatological injuries (b) of ultramarathon runners during a multi-stage ultramarathon.
Pain severity scale: 0 = no pain, 1 = minimal pain, 2 = mild pain, 3 = moderate pain, 4 = severe pain, and 5 = elimination from event. Mean ± SD
(n = 54): ††p < 0.01 vs. Stage 1
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between participants presenting DI and no-DI in the
MSUM (overall mean: 287 ± 7 mOsmol/kg). Similarly,
no statistically significant difference in PV change was
observed between participants presenting GIS and no-
GIS in the MSUM (peak value 21 ± 12 %) and the 24 h
(peak value 9 ± 11 %) and between participants present-
ing DI and no-DI in the MSUM.
Energy Balance
Gastrointestinal symptoms during the MSUM were as-
sociated with a lower daily energy intake (total p < 0.01
and adjusted p = 0.03) and greater energy deficit (78 %;
p = 0.04) compared with no-GIS (Fig. 3a). The severity
of GIS did not further disturb energy balance along the
MSUM. No significant differences in energy intake (total
and adjusted), energy expenditure, and energy deficit
were observed between GIS and no-GIS in the 24 h
(Fig. 3b). Gastrointestinal symptoms along the MSUM
were also associated with a reduction in energy intake
during running compared with no-GIS (Table 2). Fur-
thermore, greater GIS severity along the MSUM was as-
sociated with a lower energy (total (−1.5 MJ) p = 0.01
and adjusted p = 0.01) intake during running. Addition-
ally, GIS along the MSUM were associated with a lower
energy intake during the recovery period (Table 2); how-
ever, severity of GIS did not significantly exacerbate the
reduction.
The presence and severity of DI along the MSUM did
not result in significant differences of daily energy bal-
ance variables compared with no-DI. Incidence of DI did
not significantly impact on energy intake during running
(Table 3); however, greater severity of DI along the
Fig. 3 Energy expenditure, intake, and deficit of ultramarathon runners presenting (white) and not presenting (grey) gastrointestinal symptoms
during a multi-stage ultramarathon (a) and a 24-h continuous ultramarathon (b). Mean ± SD (MSUM n = 54 and 24 h n = 22): **p < 0.01 and
*p < 0.05 vs. no-GIS
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MSUM was associated with a lower energy (total
(−1.2 MJ) p = 0.02 and adjusted p = 0.01) during running.
Incidence and severity of DI did not significantly impact
on energy intake in the post-stage recovery period
(Table 3).
No acetoacetic acid was identified in pre-stage urine
samples throughout the MSUM and pre-event urine
samples in the 24 h. Acetoacetic acid (concentration
range 1.5 to 8.0 mmol/l) in post-stage urine samples was
evident in 46 % of participants at some point along the
MSUM and 90 % of participants in the 24 h. No signifi-
cant differences in pre- and post-stage acetoacetic acid
concentration were observed between GIS and no-GIS
and DI and no-DI along the MSUM. No significant
differences in pre- and post-event acetoacetic acid
concentration were observed between GIS and no-GIS
in the 24 h.
Macronutrient and Water Intake (Gastrointestinal
Symptoms vs. No-Gastrointestinal Symptoms)
The presence of GIS during the MSUM was associated
with a significant reduction in daily carbohydrate and fat
intakes, compared with no-GIS (Table 4). Conversely,
higher daily water intake was observed in participants
reporting GIS (vs. no-GIS). The severity of GIS along
the MSUM did not result in substantial differences of
daily macronutrient intake. However, greater GIS sever-
ity did result in lower daily water intake (total (−851 ml/
day) p = 0.04 and adjusted p < 0.01).
Incidence and severity of GIS during the 24 h did
not alter macronutrient and water intake variables
(total and adjusted) during running (Table 5);
whereas GIS along the MSUM were associated with
significant reductions in carbohydrate and fat intakes
during running compared with no-GIS (Table 2).
Rate of carbohydrate intake during running was also
significantly lower (−8 g/h) in participants reporting
GIS (p < 0.01 vs. no-GIS) (Fig. 4). Conversely, higher
water intake during running was observed in partici-
pants reporting GIS (vs. no-GIS). Furthermore,
greater GIS severity along the MSUM was associated
with significantly lower protein (total (−19 g) p = 0.01 and
adjusted p = 0.01), fat (total (−11 g) p = 0.03 and ad-
justed p = 0.01), and water (total (−902 ml) p = 0.01, ad-
justed p < 0.01, and rate per hour (−122 ml/h) p = 0.01)
intakes during running.
Table 2 During running and post-stage recovery energy, macronutrient, and water (through foods and fluids) intake of
ultramarathon runners presenting (GIS) and not presenting (no-GIS) gastrointestinal symptoms during a multi-stage
ultramarathon (MSUM)
During Post-stage recovery
GIS no-GIS p value GIS no-GIS p value
Energy (MJ)
Total 3.1 ± 2.0 4.0 ± 1.5 <0.05 2.4 ± 1.1 3.4 ± 1.4 <0.01
Adjusteda 0.046 ± 0.003 0.052 ± 0.002 0.36 0.036 ± 0.002 0.043 ± 0.002 0.07
Protein (g)
Total 13 ± 28 13 ± 9 0.91 14 ± 14 23 ± 13 <0.01
Adjusteda 0.2 ± 0.4 0.2 ± 0.1 0.89 0.2 ± 0.2 0.3 ± 0.2 <0.05
Carbohydrate (g)
Total 137 ± 75 175 ± 69 <0.05 108 ± 50 141 ± 87 0.07
Adjusteda 2.0 ± 0.9 2.3 ± 1.0 0.14 1.6 ± 0.8 1.6 ± 0.7 0.77
Poly (%)b 19 ± 16 26 ± 15 0.10 18 ± 21 10 ± 16 0.49
Oligo/di/mono (%)b 81 ± 16 74 ± 15 0.06 82 ± 21 90 ± 16 0.07
Fibre 3 ± 5 6 ± 4 <0.01 3 ± 3 3 ± 3 0.96
Fat (g)
Total 15 ± 16 21 ± 15 0.06 10 ± 11 18 ± 13 <0.01
Adjusteda 0.2 ± 0.2 0.3 ± 0.2 0.34 0.2 ± 0.2 0.2 ± 0.2 <0.05
Water
Total (L) 4.4 ± 1.5 3.9 ± 1.7 0.13 1.1 ± 0.6 1.5 ± 0.9 0.17
Adjusted (ml)a 65 ± 23 51 ± 22 <0.01 18 ± 10 20 ± 14 0.52
Mean ± SD (n = 54). The overall mean inter-observer coefficient of variation for energy, macronutrient, and water variables analysed were 1.3, 2.3, and
0.7 %, respectively
aAdjusted for body mass
bSaccharides
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Table 3 During running and post-stage recovery energy, macronutrient, and water (through foods and fluids) intake of ultramarathon
runners presenting (DI) and not presenting (no-DI) dermatological injuries during a multi-stage ultramarathon (MSUM)
During Post-stage recovery
DI no-DI p value DI no-DI p value
Energy (MJ)
Total 3.2 ± 2.2 3.2 ± 1.3 0.99 2.4 ± 1.2 2.6 ± 1.1 0.31
Adjusteda .046 ± .031 .048 ± .021 0.63 .036 ± .018 0.040 ± 0.017 0.15
Protein (g)
Total 13 ± 29 13 ± 12 0.93 14 ± 14 18 ± 15 0.07
Adjusteda 0.2 ± 0.4 0.2 ± 0.2 0.79 0.2 ± 0.2 0.3 ± 0.2 <0.05
Carbohydrate (g)
Total 138 ± 77 151 ± 66 0.29 107 ± 51 115 ± 48 0.34
Adjusteda 1.9 ± 0.9 2.3 ± 1.0 <0.05 1.6 ± 0.8 1.7 ± 0.7 0.27
Poly (%)b 20 ± 17 19 ± 14 0.59 16 ± 19 20 ± 23 0.78
Oligo/di/mono (%)b 80 ± 17 81 ± 14 0.10 84 ± 19 80 ± 23 0.21
Fibre 4 ± 5 3 ± 2 0.11 3 ± 3 3 ± 5 0.75
Fat (g)
Total 16 ± 18 14 ± 10 0.38 11 ± 11 13 ± 12 0.19
Adjusteda 0.2 ± 0.3 0.2 ± 0.1 0.76 0.2 ± 0.2 0.2 ± 0.2 0.25
Water
Total (L) 4.5 ± 1.6 4.1 ± 1.1 0.05 1.1 ± 0.7 1.2 ± 0.6 0.75
Adjusted (ml)a 65 ± 24 61 ± 19 0.31 18 ± 11 18 ± 9 0.96
Mean ± SD (n = 54). The overall mean inter-observer coefficient of variation for energy, macronutrient, and water variables analysed were 1.3, 2.3, and
0.7 %, respectively
aAdjusted for body mass
bSaccharides
Table 4 Daily macronutrient and water (through foods and fluids) intake of ultramarathon runners presenting and not presenting
(no-) gastrointestinal symptoms (GIS) and dermatological injuries (DI) during a multi-stage ultramarathon
GIS no-GIS p value DI no-DI p value
Protein (g)
Total 104 ± 39 114 ± 28 0.20 106 ± 39 103 ± 38 0.68
Adjusted 1.5 ± 0.6 1.4 ± 0.3 0.46 1.5 ± 0.5 1.6 ± 0.6 0.61
Carbohydrate (g)
Total 506 ± 137 635 ± 124 <0.01 516 ± 138 535 ± 151 0.39
Adjusteda 7.4 ± 2.0 7.9 ± 1.5 0.25 7.4 ± 1.8 7.8 ± 2.3 0.17
Poly (%)b 41 ± 11 35 ± 10 0.13 40 ± 11 39 ± 11 0.70
Oligo/di/mono (%)b 59 ± 11 65 ± 10 <0.01 60 ± 11 61 ± 11 0.37
Fibre 17 ± 9 29 ± 12 <0.01 18 ± 9 20 ± 12 0.35
Fat (g)
Total 90 ± 36 126 ± 57 <0.01 95 ± 42 89 ± 36 0.33
Adjusteda 1.3 ± 0.6 1.6 ± 0.7 <0.05 1.4 ± 0.6 1.3 ± 0.5 0.62
Water
Total (L) 7.8 ± 2.0 7.1 ± 2.2 0.09 7.9 ± 1.9 7.1 ± 2.1 <0.05
Adjusted (ml)a 117 ± 32 93 ± 31 <0.01 116 ± 31 109 ± 37 0.20
Mean ± SD (n = 54). The overall mean inter-observer coefficient of variation for energy, macronutrient, and water variables analysed were 1.3, 2.3, and
0.7 %, respectively
aAdjusted for body mass
bSaccharides
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Gastrointestinal symptoms along the MSUM were as-
sociated with a reduced recovery nutrition profile,
whereby significantly lower total protein, carbohydrate,
and fat intakes were observed during the post-stage
recovery period compared with no-GIS (Table 2). The
severity of GIS along the MSUM did not however result
in significant differences of macronutrient and water in-
take variables in the post-stage recovery period.
Macronutrient and Water Intake (Dermatological Injuries
vs. No-Dermatological Injuries)
Dermatological injuries along the MSUM did not result
in substantial differences of daily macronutrient intakes
compared with no-DI (Table 4). However, the presence
of DI was associated with significantly higher daily water
intake. Greater severity of DI along the MSUM was
associated with significantly lower daily fat intake (total
p = 0.01).
Dermatological injuries along the MSUM were asso-
ciated with significant reductions in total protein and
rate of carbohydrate (−4 g/h; p = 0.05; Fig. 4) intake
during running compared with no-DI (Table 3).
Conversely, higher water intake during running was
observed in participants reporting DI (vs. no-DI).
Greater severity of DI along the MSUM was associ-
ated with significantly lower carbohydrate (total
(−40 g) p = 0.03 and rate per hour (−6 g/h) p = 0.02)
intake and rate of water intake per hour (−105 ml/h;
p = 0.02) during running.
The presence of DI along the MSUM did not signifi-
cantly reduced recovery nutrition profile (Table 3). How-
ever, greater severity of DI along the MSUM was
associated with significant reductions in the recovery nu-
trition profile, whereby lower protein (0.1 g/kg; adjusted
p = 0.02) and water (total (−270 ml) p = 0.04 and ad-
justed p = 0.02) intakes were observed with increased
severity.
Table 5 Macronutrient and water (through foods and fluids)
intake of ultramarathon runners presenting and not presenting
(no-) gastrointestinal symptoms (GIS) during a 24-h continuous
ultramarathon
GIS no-GIS p value
Protein (g)
Total 79 ± 31 109 ± 49 0.12
Adjusteda 1.3 ± 0.4 1.3 ± 0.5 0.46
Carbohydrate (g)
Total 937 ± 683 759 ± 184 0.54
Adjusteda 12.4 ± 8.7 8.7 ± 1.7 0.29
Poly (%)b 31 ± 10 33 ± 18 0.60
Oligo/di/mono (%)b 69 ± 10 67 ± 18 0.56
Fibre 23 ± 10 22 ± 15 0.82
Fat (g)
Total 104 ± 53 143 ± 47 0.15
Adjusteda 1.1 ± 0.7 1.7 ± 0.6 0.51
Water
Total (L) 9.1 ± 4.2 9.1 ± 3.8 0.98
Adjusted (ml)a 125 ± 54 105 ± 44 0.45
Mean ± SD (n = 22). The overall mean inter-observer coefficient of variation for
energy, macronutrient, and water variables analysed were 0.8, 1.4, and
0.5 %, respectively
aAdjusted for body mass
bSaccharides
Fig. 4 Rate of carbohydrate intake during running of ultramarathon runners presenting (GIS) and not presenting (no-GIS) gastrointestinal
symptoms during a multi-stage ultramarathon (MSUM) and a 24-h continuous ultramarathon (24 h). Values compared to carbohydrate intake
recommendation for glucose (short broken line) and glucose-fructose (long broken line) [43]. Mean ± SD (MSUM n = 54 and 24 h n = 22):
**p < 0.01 vs. no-GIS
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Discussion
The current study aimed to determine whether GIS or DI
affects food and fluid intake, and nutrition and hydration
status, of ultramarathon runners during multi-stage and
24-h ultra-marathons. Gastrointestinal symptoms were a
common feature in both the MSUM and 24 h; however,
reported incidence of DI requiring self-management and
(or) medical intervention were high during the MSUM,
but relatively low during the 24 h. The presence of GIS
appeared to be associated with greater disturbances to
daily energy balance, reduced daily macronutrient intake,
and reduced nutritional intake during running and recov-
ery throughout the MSUM. Similarly, the presence of DI
appeared to be associated with reduced nutritional intake
during running and recovery throughout the MSUM.
Increasing severity of GIS and DI along the MSUM was
associated with further reductions in energy, macronutri-
ent, and fluid intakes. Gastrointestinal symptom incidence
and severity did not alter energy, macronutrient, and fluid
intakes during the 24 h. From a performance perspective
and considering previous research has identified perform-
ance issues with GIS and DI [18], these clinical
manifestation resulted in a longer time to complete the
MSUM, but not distance covered in the 24 h, despite not
reaching significance possibly due to large individual vari-
ations within group comparisons.
In both events, upper-GIS and nausea were the
most commonly reported symptoms, with lower-GIS
(i.e. predominantly diarrhoea) incidence being
reported to a lesser extent. These results are in ac-
cordance with previous field observations, whereby
89 % of ultramarathon runners presenting gastrointes-
tinal distress during a 161-km ultramarathon also
reported nausea, whilst abdominal cramping (44 %)
and diarrhoea (44 %) were reported to a lesser extent
[17, 18]. Such observations are however contrary to
previously reported indications that lower-GIS are the
predominant GIS during running [14]. Moreover, inci-
dence of GIS were greater than those previously re-
ports during long distance triathlon events, marathon,
and ultramarathon running [14, 17]. This finding is
not surprising, considering the greater exertional and
thermoregulatory strain compared with previous stud-
ies. It is unfortunate that on this occasion, the timing
or distance at which symptoms occurred was not de-
termined. If ultramarathon runners presented symp-
tom later, after running onset, it would be expected
to have lesser impact on nutritional intake than if
symptoms were presented earlier. Considering the
field setting of the study and the competitive nature
of the events, the current study design per se did not
allow symptom data to be collected during the actual
competitive segment of each event. However, recent
preliminary data from controlled laboratory trials has
indicated GIS significantly increasing by 30 min
(equivalent to 5.0-km distance point) and remained
elevated thereafter, during a 3 h running protocol in
thermoneutral condition (23.3 °C, 51 % RH) whereby
participants consumed 30 g carbohydrate (2:1 glucose
to fructose ratio) every 20 min [42, 43].
Taking into account that (a) no significant difference
in GIS incidence and severity was seen between stages in
the MSUM, (b) participants reported symptoms ‘coming
and going’ along the consecutive days of competition,
and (c) the variety of symptoms reported in both events;
the precise causal mechanism/s for the high GIS inci-
dence is not clear, but appears to be multi-factorial in
origin. Exertion induced splanchnic hypoperfusion, is-
chemia, mechanical trauma, neuroendocrine stimulation,
altered gastrointestinal motility, malabsorption, and al-
tered epithelial permeability have all been directly or in-
directly implicated [15, 20–26, 44]. It is however likely
that the exertional heat stress exposure along the
MSUM substantially contributed to the high GIS rates,
since greater perturbations to gastrointestinal integrity
(i.e. splanchnic hypoperfusion, splanchnic ischemia, and
increase epithelial permeability) have been observed in
heat stress experimental models (>30 °C ambient
temperature) compared with thermoneutral conditions
[21, 24, 45]. Indeed, lower perceptive tolerance rating to
heat has been associated with greater reports of GIS in
ultramarathon runners [5]. Moreover, daily and during
running water intakes (through foods and fluids) were
observed to be greater in ultramarathon runners report-
ing GIS. Since over-drinking behaviours and asymptom-
atic hyponatraemia were evident in the current MSUM
event [41], it is possible that fluid intake strategies of ul-
tramarathon runners may have also contribute to GIS
[27–29], especially upper-GIS (e.g. gastric fluid load
above individual tolerance), nausea, and vomiting (e.g.
hyponatraemia). Gastrointestinal symptoms along the
24 h were likely to have been induced by the extreme
duration of exertional stress, with or without feeding tol-
erance (i.e. forced feeding of scheduled dietary strategy)
[15, 46, 47]. Similar to the 24 h findings, total carbohy-
drate intake rates have been reported to be positively
correlated with nausea and GIS, but resulted in faster
finishing times in long distance triathlon events [14].
Systemic endotoxaemic and cytokinaemic responses
were observed in the current MSUM and 24 h events
[25, 26]. Such responses have also been linked to GIS;
therefore, exertional or exertional heat stress induced in-
testinal bacteria translocation and subsequent systemic
inflammatory responses cannot be discounted as GIS
promoters during ultramarathon events. On this occa-
sion, during both the MSUM and 24 h, the type of car-
bohydrates consumed (i.e. quantity of highly resistant
and fermentable carbohydrates associated with GIS [48])
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did not differ between GIS and no-GIS. This suggests
that gastrointestinal mechanisms and intake volumes are
potentially responsible for GIS and not necessarily food
and fluid choices. It is worth noting that excessive
carbohydrate intakes during exercise above individually
tolerated levels may directly contribute to the high oc-
currence of upper-GIS through neural and humoral-
driven pathways stimulating the ileal break [30]. It is
thus evident that GIS during ultramarathon running is
multi-factorial. Conducting a series of controlled labora-
tory experiments to assess exertional stress (with and
without heat stress) on gastrointestinal integrity and
functional markers, and links to symptoms, would shed
light on the key aetiological pathways of exertional in-
duced upper- and lower-GIS.
Considering the already compromised nutrition status
of ultramarathon runners during MSUM and 24 h
events [5, 6], GIS further compromised the ability to
consume energy, macronutrients, and fluid along the
MSUM, but not during the 24 h. Indeed, compared with
no-GIS, incidence of GIS were associated with (1) lower
daily energy, carbohydrate, and fat intakes; (2) lower en-
ergy and carbohydrate intakes during running; and (3)
poorer recovery nutrition throughout the MSUM. The
severity of GIS appeared not to impact on total daily en-
ergy and macronutrient intakes, but high severity did re-
sult in a lower total daily water intake. The severity of
GIS also appeared not to impact on recovery nutrition,
but high severity did result in lower energy, protein, fat,
and water intakes during running. Thus, the debatable
question is whether symptoms per se limited the ability
to consume foods and fluids or whether additional nutri-
ent availability in the gastrointestinal tract prevented or
suppressed symptoms. It has previously been shown that
carbohydrate ingestion before and during exertion atten-
uated the reductions in post-exercise superior mesen-
teric artery and portal vein blood flow by Doppler
method [49, 50]. This suggests that nutrient presence in
the gastrointestinal tract may be protective against exer-
tion induced splanchnic hypoperfusion and subsequent
associated damage and symptoms [51].
The current study was the first to comprehensively as-
sess DI during various ultramarathon events and its im-
pact on nutritional intake and status. Dermatological
injuries that warranted self-management and (or) med-
ical intervention were a common feature during the
MSUM; but relatively low incidence was observed in the
24 h. The discrepancy between the MSUM and 24 h is
likely due to MSUM participants having sufficient time
to manage DI, whilst stopping during the 24 h event
would cost the participant valuable time. It is speculated
that incidence of DI were likely to be substantially
higher in the 24 h, but participants did not choose to
investigate damage during the event. Nevertheless,
incidence and severity of DI increased as the MSUM
progressed. Foot injury (e.g. blisters) was the most com-
mon DI reported, with severity of foot injury associated
with infection, local inflammation, and pain. Participants
reported investing time and effort into self-management
or seeking and receiving medical attention for injuries.
This was especially apparent from Stage 3 onwards, in
which medical crews reported observing concerning
levels of infection and inflammation surrounding blisters
in several participants.
Dermatological injuries were associated with a lower
rate of carbohydrate intake during running, but the inci-
dence of DI did not promote any additional decrements in
other nutritional and hydration status variables per se
compared with no-DI. However, as the severity of DI in-
creased, lower energy, carbohydrate, and water intakes
during running and lower protein and water intakes as
part of recovery nutrition were observed. It thus appears,
the greater the number of DI and subsequent progressive
presentation of infection, inflammation, and pain, the
more attention is focused towards the management and
treatment of injuries, whilst nutrition was deprioritised.
From a performance and clinical perspective, carbohy-
drate energy substrate plays a crucial role in exercise per-
formance [43, 52], fatigue attenuation [12], and immune
competence [53] during periods of exertional stress. Sub-
optimal daily and during exercise carbohydrate intake has
been linked with hormonal (e.g. cortisol) and immune
(e.g. cytokine profile and innate immune responses) dys-
function, potentially leading to states of chronic fatigue
and depressed immunity [11, 12, 53, 54]. Additionally,
carbohydrate, protein, and water play a fundamental role
in recovery processes, with poor recovery nutrition being
linked to reduced glycogen and tissue protein synthesis,
hypohydration, and immunodepression [8, 9, 43, 53, 55,
56]. Indeed, positive correlations have been observed be-
tween energy and carbohydrate intakes with perceived re-
covery quality during a multi-stage ultramarathon event
[5]. It is thus concerning that incidence and severity of
both GIS and DI promoted further reductions in daily,
during exercise, and recovery nutrition.
Conclusions
High rates of GIS were reported in both events; however,
incidence and severity of GIS only negatively altered nutri-
tional intake during MSUM. Dermatological injury inci-
dence and severity reduced nutrient intake during
running and recovery in the MSUM. Considering the
already compromised nutritional status of ultramarathon
runners during multi-stage events, these findings demon-
strate that GIS and DI further compromises intake. Effect-
ive GIS and DI prevention and management strategies
should be investigated, especially in respect to consecutive
days of exertional stress.
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